KVUE / 3 Healthcare Stocks to Buy as the Market Gets Defensive

Kenvue stock pays a fairly high dividend that yields 4.4%. The company is expecting modest revenue growth of around 6% this year. more_horizontal

Kenvue Inc (NYSE:KVUE ) Q3 2023 Earnings Conference Call October 26, 2023 8:30 AM ET Company Participants Tina Romani - Head of Investor Relations Thi more_horizontal

Kenvue CEO Thibaut Mongon joins ‘Squawk on the Street' to discuss the company's latest quarter, their new products in the market, and more. more_horizontal

Kenvue Inc's shares fell 1.7% in pre-market trading after the company posted in-line third-quarter earnings but tightened its full-year guidance after more_horizontal

Kenvue Inc.'s stock KVUE, -1.25% fell 2.4% in premarket trade Thursday, after the company posted in-line third-quarter earnings but tightened its full more_horizontal

Kenvue on Thursday reported higher third-quarter revenue, owing to strong demand for its self-care and skincare products such as Tylenol and Neutrogen more_horizontal

Gina Sanchez, Lido Advisors chief market strategist, joins 'The Exchange' to discuss IPOs performing below their debut prices, defensive IPO names to more_horizontal

Kenvue Inc., a subsidiary of Johnson & Johnson, is a major player in the consumer health industry with a diverse range of products. The company succes more_horizontal